Similar results were obtained for the ratio of IL-10 to TNF-α, whereby F(ab′)2 epratuzumab significantly influenced the cytokine balance toward IL-10 in B cells from patients with SLE (p < 0.01) (Fig. 3b). Here, TNF is linked to systemic lupus erythematosus.